We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

The company develops, manufactures, distributes, and sells technologies and devices for cataract, retinal, refractive surgery, as well as contact lenses and lens care products. Read More on ALC: Alcon ...

Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.

Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reported third quarter results ...

The company will offer a cataract-only system called UNITY CS ... Globally, one out of every three IOLs implanted is done ...

The annual China International Import Expo (CIIE) taking place in Shanghai serves as a prime platform for foreign companies to showcase innovations, breakthrough technologies, and quality products; ...

Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago ...

Precision7 is a new one-week replacement contact lens ... on Alcon’s expertise in surgical equipment with pioneering innovations to deliver breakthrough workflow efficiencies that enable excellent ...

BERLIN — Technological advancements and the development of intraocular lenses (IOLs) have significantly improved the care of ...

Alcon, Inc. engages in the development ... consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma.